HDR Gateway logo
HDR Gateway logo

Bookmarks

Genomics England - Rare Disease

Population Size

Not reported

Years

2014 - 2019

Associated BioSamples

None/not available

Geographic coverage

Not reported

Lead time

2-6 months

Summary

Rare Disease (RD) data are presented at the level of RD families, RD pedigrees, and participants. Participants are consenting individuals who have had their genome sequenced. Pedigree members are extended members of the proband’s family.

Documentation

Rare Disease data are presented at the level of Rare Disease families (families of probands), Rare Disease pedigrees, and participants. Participants are individuals who have consented to be part of the project with the expectation that a sample of their DNA will be obtained and their genome sequenced. Pedigree members are extended members of the proband’s family, this includes participants as well a small amounts of deidentified data recorded to allow a full picture of the proband’s extended family. This additional information is extracted from the proband’s medical record.

All Rare Disease table names are prefixed with “rarediseases”.

Data at the Level of Rare Disease Families:

rare_diseases_family:

Data describing the families of rare disease probands participating in the 100,000 Genomes Project. It includes the family group type, the status of the family’s pre-interpretation clinical review and the settings that were chosen for the interpretation pipeline at the clinical review.

rare_diseases_pedigree:

Data describing the Rare Disease participants, linking pedigrees to probands and their family members.

rare_diseases_pedigree_member:

Data describing the Rare Disease pedigree members, similar to the data about each individual participant in the participant table (common data view, see section 8.2). It may also include additional data, such as the age of onset of predominant clinical features; data on links to other family members; as well as data collected only for Phenotypes.

Data at the Level of Rare Disease Participants.

The data presented in these tables provides information on disease progression and pertinent medical history:

rare_diseases_participant_disease:

Data describing the rare disease participants' disease type/subtype assigned to them upon enrolment, and the date of diagnosis.

rare_diseases_participant_phenotype:

Data describing the Rare Disease participants’ phenotypes. For each Rare Disease participant in the 100,000 Genomes Project, there are data about whether a phenotypic abnormality as defined by an HPO term is present and what the HPO term is, as well as the age of onset, the severity of manifestation, the spatial pattern in the body and whether it is progressive or not. Please note that these data are only available for a subset of the rare disease participants.

rare_diseases_gen_measurement:

For Rare Disease participants in the 100,000 Genomes Project, this table contains general measurements relevant to the disease, alongside the date that the measurements were taken on. Please note that these data are only available for a subset of the rare disease participants.

rare_diseases_early_childhood_observation:

For Rare Disease participants in the 100,000 Genomes Project, this table contains measurements and milestones provided by the GMCs, related to childhood development. Please note that these data are only available for a subset of the rare disease participants.

r

Dataset type
Health and disease
Dataset sub-type
Not applicable

Keywords

DNA, Genomics, DATA-CAN, Data, Genome, Rare Disease

Observations

Observed Node
Disambiguating Description
Measured Value
Measured Property
Observation Date

Persons

Cancer Tumour - Number of genomes

Not reported

Count

01 Jan 1970

Persons

Rare Disease Participants

Not reported

Count

01 Jan 1970

Persons

Cancer Germline - Number of genomes

Not reported

Count

01 Jan 1970

Persons

Cancer Participants

Not reported

Count

01 Jan 1970

Persons

Rare Disease - Number of genomes

Not reported

Count

01 Jan 1970

Provenance

Patient pathway description
Linked datasets cover secondary care.
Image contrast
Not stated
Biological sample availability
None/not available

Structural Metadata

Details

Publishing frequency
Quarterly
Version
17.0.0
Modified

08/10/2024

Distribution release date

30/03/2023

Citation Requirements
The 100;,;000 Genomes Project Protocol v3;,;Genomics England. doi:10.6084/m9.figshare.4530893.v3. 2017. Publications that use the Genomics England Database should include an author as Genomics England Research Consortium. Please see the publication policy.

Coverage

Start date

01/01/2014

End date

01/01/2019

Time lag
2-6 months
Maximum age range
150
Follow-up
Other

Accessibility

Language
en
Controlled vocabulary
OTHER, SNOMED CT, HPO, OPCS4
Format
Multiple Formats Available

Data Access Request

Dataset pipeline status
Not available
Time to dataset access
2-6 months
Access request cost
Fees will be dependent on the type of access that is necessary. Raw data is not eligible for export. Summary-level data may be exported provided that it is approved through the Genomics England Airlock Process
Access service description
More information about the Genomics England Research Environment can be found here: https://www.genomicsengland.co.uk/about-genomics-england/research-environment/ https://research-help.genomicsengland.co.uk/display/GERE/1.+The+Genomics+England+Research+Environment Genomics England 100k participants have consented to longitudinal lifetime followup and recontact safely through our clinical network. BRST (Bioinformatics Research Services) are a team of bioinformatics who know the dataset inside out and provide consultancy projects on a case by case basis. Our network of clinical and medical experts can be made available on case by case basis. Researchers have the opportunity to work with our and access the GeCIP network who are a community of world-leading experts in specific cancers and rare diseases.
Jurisdiction
GB-GBN
Data Controller
GENOMICS ENGLAND
Data Processor
GENOMICS ENGLAND

Dataset Types: Health and disease


Collection Sources:

Relationships: